4DMedical secures US$100+ million to accelerate US Expansion
Posted: 29 January 2026 4DMedical has secured more than US$100 million (approximately AU$150 million) in new institutional funding, with the capital having been raised to accelerate U.S. market expansion and strengthen its leadership in software-based lung imaging. “This…
BioNTech outlines strategic updates and priorities at 44th annual JP Morgan Healthcare Conference
Posted: 15 January 2026 BioNTech SE has outlined its strategic updates and priorities for 2026, with the year positioned as a milestone-rich period for its oncology pipeline, during an update delivered at the J.P. Morgan Healthcare Conference in…
Peter MacCallum Cancer Centre awarded more than $7.5 million in NHMRC Ideas Grants to advance cancer research
Posted: 15 January 2026 Peter MacCallum Cancer Centre has been awarded more than $7.5 million through the National Health and Medical Research Council (NHMRC) Ideas Grants, with five projects having been funded to investigate cancer spread, treatment resistance…
Monash University awarded $53.3 million through NHMRC Ideas Grants
Posted: 15 January 2026 Monash University researchers have been awarded $53.3 million through the National Health and Medical Research Council (NHMRC) Ideas Grant scheme, with 32 projects having received funding to support innovative health and medical research across…
Chimeric Therapeutics granted FDA Orphan Drug Designation for CHM CDH17 in gastric cancer
Posted: 8 December 2025 Chimeric Therapeutics Ltd has been granted Orphan Drug Designation by the US Food and Drug Administration (FDA) for CHM CDH17 in the treatment of gastric cancer. The designation is recognised as a significant milestone…
Cartherics launches spin-out Evinco to advance immune-based therapies for Alzheimer’s disease
Posted: 8 December 2025 Evinco Therapeutics Pty Ltd has been officially launched in Melbourne as a new biotechnology company dedicated to transforming treatments for Alzheimer’s disease and other neuroinflammatory conditions. Based in Melbourne and led by CEO and…
Thermo Fisher Scientific expands Bioprocess Design Centers to strengthen Asia’s biopharma manufacturing capacity
Posted: 5 December 2025 Thermo Fisher Scientific announces a significant expansion of its Bioprocess Design Centers across Asia, deepening its investment in the region’s rapidly advancing biopharmaceutical sector. The company is opening a new centre in Hyderabad, India,…
New MTPConnect report highlights strong commercial and clinical outcomes from its CTCM Medtech program
Posted: 5 December 2025 A new report has been released detailing the strong outcomes achieved through MTPConnect’s Clinical Translation Commercialisation Medtech (CTCM) Programme, highlighting the advances made by emerging Australian medtech companies supported through the initiative. Speaking at…
CSL Seqirus opens world-class $1bn vaccine and antivenom manufacturing facility in Melbourne
Posted: 5 December 2025 Australia’s onshore vaccine manufacturing capabilities took a leap forward today as The Hon Mark Butler MP, Minister for Health, Disability and Ageing, opened CSL Seqirus’ state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in…
Florey Institute study reveals neural activity directly drives faster glioma growth
Posted: 1 December 2025 A new study led by The Florey has revealed that heightened neural excitability in the brain directly drives increased growth of glioma, an aggressive and currently incurable form of brain cancer. “Glioma is a…
Akesa unveils new Aksys digital platform to streamline access to private-script medicines in hospitals
Posted: 1 December 2025 Akesa has launched the Aksys platform as a digital solution designed to simplify how Australian hospitals access non-Pharmaceutical Benefits Scheme (PBS) reimbursed prescription medicines. The platform is positioned as a major advancement in improving…
4DMedical celebrated as a high-growth Australian innovator, ranking seventh in Deloitte’s Tech Fast 50
Posted: 1 December 2025 4DMedical has been ranked seventh in the Deloitte 2025 Tech Fast 50 after recording a 715% increase in revenue across the past three years. The ranking is a recognition of the organisation’s rapid expansion…
